Global Immuno-Oncology Market Growth (Status and Outlook) 2024-2031

Report ID: 1168279 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Immuno-Oncology Market Size 2017-2028
        2.1.2 Immuno-Oncology Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Immuno-Oncology Segment by Type
        2.2.1 Immune Checkpoint Inhibitors
        2.2.2 Cytokine-Based Immunotherapy
        2.2.3 Cancer Vaccines
        2.2.4 CAR-T Cell Therapy
        2.2.5 Others
    2.3 Immuno-Oncology Market Size by Type
        2.3.1 Immuno-Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Immuno-Oncology Market Size Market Share by Type (2017-2022)
    2.4 Immuno-Oncology Segment by Application
        2.4.1 Hospitals
        2.4.2 Drugstores
        2.4.3 Others
    2.5 Immuno-Oncology Market Size by Application
        2.5.1 Immuno-Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Immuno-Oncology Market Size Market Share by Application (2017-2022)
3 Immuno-Oncology Market Size by Player
    3.1 Immuno-Oncology Market Size Market Share by Players
        3.1.1 Global Immuno-Oncology Revenue by Players (2020-2022)
        3.1.2 Global Immuno-Oncology Revenue Market Share by Players (2020-2022)
    3.2 Global Immuno-Oncology Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Immuno-Oncology by Regions
    4.1 Immuno-Oncology Market Size by Regions (2017-2022)
    4.2 Americas Immuno-Oncology Market Size Growth (2017-2022)
    4.3 APAC Immuno-Oncology Market Size Growth (2017-2022)
    4.4 Europe Immuno-Oncology Market Size Growth (2017-2022)
    4.5 Middle East & Africa Immuno-Oncology Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Immuno-Oncology Market Size by Country (2017-2022)
    5.2 Americas Immuno-Oncology Market Size by Type (2017-2022)
    5.3 Americas Immuno-Oncology Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Immuno-Oncology Market Size by Region (2017-2022)
    6.2 APAC Immuno-Oncology Market Size by Type (2017-2022)
    6.3 APAC Immuno-Oncology Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Immuno-Oncology by Country (2017-2022)
    7.2 Europe Immuno-Oncology Market Size by Type (2017-2022)
    7.3 Europe Immuno-Oncology Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Immuno-Oncology by Region (2017-2022)
    8.2 Middle East & Africa Immuno-Oncology Market Size by Type (2017-2022)
    8.3 Middle East & Africa Immuno-Oncology Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Immuno-Oncology Market Forecast
    10.1 Global Immuno-Oncology Forecast by Regions (2023-2028)
        10.1.1 Global Immuno-Oncology Forecast by Regions (2023-2028)
        10.1.2 Americas Immuno-Oncology Forecast
        10.1.3 APAC Immuno-Oncology Forecast
        10.1.4 Europe Immuno-Oncology Forecast
        10.1.5 Middle East & Africa Immuno-Oncology Forecast
    10.2 Americas Immuno-Oncology Forecast by Country (2023-2028)
        10.2.1 United States Immuno-Oncology Market Forecast
        10.2.2 Canada Immuno-Oncology Market Forecast
        10.2.3 Mexico Immuno-Oncology Market Forecast
        10.2.4 Brazil Immuno-Oncology Market Forecast
    10.3 APAC Immuno-Oncology Forecast by Region (2023-2028)
        10.3.1 China Immuno-Oncology Market Forecast
        10.3.2 Japan Immuno-Oncology Market Forecast
        10.3.3 Korea Immuno-Oncology Market Forecast
        10.3.4 Southeast Asia Immuno-Oncology Market Forecast
        10.3.5 India Immuno-Oncology Market Forecast
        10.3.6 Australia Immuno-Oncology Market Forecast
    10.4 Europe Immuno-Oncology Forecast by Country (2023-2028)
        10.4.1 Germany Immuno-Oncology Market Forecast
        10.4.2 France Immuno-Oncology Market Forecast
        10.4.3 UK Immuno-Oncology Market Forecast
        10.4.4 Italy Immuno-Oncology Market Forecast
        10.4.5 Russia Immuno-Oncology Market Forecast
    10.5 Middle East & Africa Immuno-Oncology Forecast by Region (2023-2028)
        10.5.1 Egypt Immuno-Oncology Market Forecast
        10.5.2 South Africa Immuno-Oncology Market Forecast
        10.5.3 Israel Immuno-Oncology Market Forecast
        10.5.4 Turkey Immuno-Oncology Market Forecast
        10.5.5 GCC Countries Immuno-Oncology Market Forecast
    10.6 Global Immuno-Oncology Forecast by Type (2023-2028)
    10.7 Global Immuno-Oncology Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Bristol-Myers Squibb
        11.1.1 Bristol-Myers Squibb Company Information
        11.1.2 Bristol-Myers Squibb Immuno-Oncology Product Offered
        11.1.3 Bristol-Myers Squibb Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Bristol-Myers Squibb Main Business Overview
        11.1.5 Bristol-Myers Squibb Latest Developments
    11.2 Merck & Co., Inc.
        11.2.1 Merck & Co., Inc. Company Information
        11.2.2 Merck & Co., Inc. Immuno-Oncology Product Offered
        11.2.3 Merck & Co., Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Merck & Co., Inc. Main Business Overview
        11.2.5 Merck & Co., Inc. Latest Developments
    11.3 Roche AG
        11.3.1 Roche AG Company Information
        11.3.2 Roche AG Immuno-Oncology Product Offered
        11.3.3 Roche AG Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Roche AG Main Business Overview
        11.3.5 Roche AG Latest Developments
    11.4 AstraZeneca, Plc
        11.4.1 AstraZeneca, Plc Company Information
        11.4.2 AstraZeneca, Plc Immuno-Oncology Product Offered
        11.4.3 AstraZeneca, Plc Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 AstraZeneca, Plc Main Business Overview
        11.4.5 AstraZeneca, Plc Latest Developments
    11.5 Sanofi S.A.
        11.5.1 Sanofi S.A. Company Information
        11.5.2 Sanofi S.A. Immuno-Oncology Product Offered
        11.5.3 Sanofi S.A. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Sanofi S.A. Main Business Overview
        11.5.5 Sanofi S.A. Latest Developments
    11.6 Dendreon Pharmaceuticals
        11.6.1 Dendreon Pharmaceuticals Company Information
        11.6.2 Dendreon Pharmaceuticals Immuno-Oncology Product Offered
        11.6.3 Dendreon Pharmaceuticals Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Dendreon Pharmaceuticals Main Business Overview
        11.6.5 Dendreon Pharmaceuticals Latest Developments
    11.7 Novartis
        11.7.1 Novartis Company Information
        11.7.2 Novartis Immuno-Oncology Product Offered
        11.7.3 Novartis Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Novartis Main Business Overview
        11.7.5 Novartis Latest Developments
    11.8 Gilead Sciences Inc.
        11.8.1 Gilead Sciences Inc. Company Information
        11.8.2 Gilead Sciences Inc. Immuno-Oncology Product Offered
        11.8.3 Gilead Sciences Inc. Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Gilead Sciences Inc. Main Business Overview
        11.8.5 Gilead Sciences Inc. Latest Developments
    11.9 Merck KGaA
        11.9.1 Merck KGaA Company Information
        11.9.2 Merck KGaA Immuno-Oncology Product Offered
        11.9.3 Merck KGaA Immuno-Oncology Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Merck KGaA Main Business Overview
        11.9.5 Merck KGaA Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Immuno-Oncology Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Immune Checkpoint Inhibitors
    Table 3. Major Players of Cytokine-Based Immunotherapy
    Table 4. Major Players of Cancer Vaccines
    Table 5. Major Players of CAR-T Cell Therapy
    Table 6. Major Players of Others
    Table 7. Immuno-Oncology Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Immuno-Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Immuno-Oncology Market Size Market Share by Type (2017-2022)
    Table 10. Immuno-Oncology Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Immuno-Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Immuno-Oncology Market Size Market Share by Application (2017-2022)
    Table 13. Global Immuno-Oncology Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Immuno-Oncology Revenue Market Share by Player (2020-2022)
    Table 15. Immuno-Oncology Key Players Head office and Products Offered
    Table 16. Immuno-Oncology Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Immuno-Oncology Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Immuno-Oncology Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Immuno-Oncology Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Immuno-Oncology Market Size Market Share by Country (2017-2022)
    Table 23. Americas Immuno-Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Immuno-Oncology Market Size Market Share by Type (2017-2022)
    Table 25. Americas Immuno-Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Immuno-Oncology Market Size Market Share by Application (2017-2022)
    Table 27. APAC Immuno-Oncology Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Immuno-Oncology Market Size Market Share by Region (2017-2022)
    Table 29. APAC Immuno-Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Immuno-Oncology Market Size Market Share by Type (2017-2022)
    Table 31. APAC Immuno-Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Immuno-Oncology Market Size Market Share by Application (2017-2022)
    Table 33. Europe Immuno-Oncology Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Immuno-Oncology Market Size Market Share by Country (2017-2022)
    Table 35. Europe Immuno-Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Immuno-Oncology Market Size Market Share by Type (2017-2022)
    Table 37. Europe Immuno-Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Immuno-Oncology Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Immuno-Oncology Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Immuno-Oncology Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Immuno-Oncology Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Immuno-Oncology Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Immuno-Oncology Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Immuno-Oncology
    Table 46. Key Market Challenges & Risks of Immuno-Oncology
    Table 47. Key Industry Trends of Immuno-Oncology
    Table 48. Global Immuno-Oncology Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Immuno-Oncology Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Immuno-Oncology Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Immuno-Oncology Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Immuno-Oncology Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Immuno-Oncology Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Bristol-Myers Squibb Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 55. Bristol-Myers Squibb Immuno-Oncology Product Offered
    Table 56. Bristol-Myers Squibb Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Bristol-Myers Squibb Main Business
    Table 58. Bristol-Myers Squibb Latest Developments
    Table 59. Merck & Co., Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 60. Merck & Co., Inc. Immuno-Oncology Product Offered
    Table 61. Merck & Co., Inc. Main Business
    Table 62. Merck & Co., Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Merck & Co., Inc. Latest Developments
    Table 64. Roche AG Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 65. Roche AG Immuno-Oncology Product Offered
    Table 66. Roche AG Main Business
    Table 67. Roche AG Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Roche AG Latest Developments
    Table 69. AstraZeneca, Plc Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 70. AstraZeneca, Plc Immuno-Oncology Product Offered
    Table 71. AstraZeneca, Plc Main Business
    Table 72. AstraZeneca, Plc Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. AstraZeneca, Plc Latest Developments
    Table 74. Sanofi S.A. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 75. Sanofi S.A. Immuno-Oncology Product Offered
    Table 76. Sanofi S.A. Main Business
    Table 77. Sanofi S.A. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Sanofi S.A. Latest Developments
    Table 79. Dendreon Pharmaceuticals Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 80. Dendreon Pharmaceuticals Immuno-Oncology Product Offered
    Table 81. Dendreon Pharmaceuticals Main Business
    Table 82. Dendreon Pharmaceuticals Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Dendreon Pharmaceuticals Latest Developments
    Table 84. Novartis Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 85. Novartis Immuno-Oncology Product Offered
    Table 86. Novartis Main Business
    Table 87. Novartis Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Novartis Latest Developments
    Table 89. Gilead Sciences Inc. Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 90. Gilead Sciences Inc. Immuno-Oncology Product Offered
    Table 91. Gilead Sciences Inc. Main Business
    Table 92. Gilead Sciences Inc. Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Gilead Sciences Inc. Latest Developments
    Table 94. Merck KGaA Details, Company Type, Immuno-Oncology Area Served and Its Competitors
    Table 95. Merck KGaA Immuno-Oncology Product Offered
    Table 96. Merck KGaA Main Business
    Table 97. Merck KGaA Immuno-Oncology Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Merck KGaA Latest Developments
List of Figures
    Figure 1. Immuno-Oncology Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Immuno-Oncology Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Immuno-Oncology Market Size Market Share by Type in 2021
    Figure 7. Immuno-Oncology in Hospitals
    Figure 8. Global Immuno-Oncology Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Immuno-Oncology in Drugstores
    Figure 10. Global Immuno-Oncology Market: Drugstores (2017-2022) & ($ Millions)
    Figure 11. Immuno-Oncology in Others
    Figure 12. Global Immuno-Oncology Market: Others (2017-2022) & ($ Millions)
    Figure 13. Global Immuno-Oncology Market Size Market Share by Application in 2021
    Figure 14. Global Immuno-Oncology Revenue Market Share by Player in 2021
    Figure 15. Global Immuno-Oncology Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Immuno-Oncology Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Immuno-Oncology Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Immuno-Oncology Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Immuno-Oncology Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Immuno-Oncology Value Market Share by Country in 2021
    Figure 21. Americas Immuno-Oncology Consumption Market Share by Type in 2021
    Figure 22. Americas Immuno-Oncology Market Size Market Share by Application in 2021
    Figure 23. United States Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Immuno-Oncology Market Size Market Share by Region in 2021
    Figure 28. APAC Immuno-Oncology Market Size Market Share by Application in 2021
    Figure 29. China Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Immuno-Oncology Market Size Market Share by Country in 2021
    Figure 36. Europe Immuno-Oncology Market Size Market Share by Type in 2021
    Figure 37. Europe Immuno-Oncology Market Size Market Share by Application in 2021
    Figure 38. Germany Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Immuno-Oncology Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Immuno-Oncology Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Immuno-Oncology Market Size Market Share by Application in 2021
    Figure 46. Egypt Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Immuno-Oncology Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 55. United States Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 59. China Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 63. India Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 66. France Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 67. UK Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Immuno-Oncology Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Immuno-Oncology Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Immuno-Oncology Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Immuno-Oncology Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Immuno-Oncology Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports